Department of Defense Pharmacy Uniform Formulary Blanket Purchase Agreement/ Uniform Formulary Additional Discount Program

SolicitationNo Set AsideActive

Key Takeaways

  • Set-aside for No Set Aside businesses
  • Work to be performed in JBSA FT SAM HOUSTON, TX
  • Industry: Pharmaceutical Preparation Manufacturing

Contract Details

Notice ID
HT9402-26-Q-9201
Opportunity Type
Solicitation
Sub-Agency
DEFENSE HEALTH AGENCY (DHA)
Office
DEFENSE HEALTH AGENCY (DHA)
Posted Date
Tuesday, February 10, 2026
Response Deadline
Thursday, April 2, 2026
PSC Code
6505
Set-Aside
No Set Aside
Place of Performance
JBSA FT SAM HOUSTON, TX, 78234
Status
Active

Description

The Department of Defense (DoD) is required by law (10 U.S.C. 1074g) to establish an effective, efficient, integrated pharmacy benefits program for the Military Health System (MHS) which includes the purchase pharmaceutical agents. The law and implementing regulation (32 CFR Section 199.21) describe the process by which the DoD Pharmacy and Therapeutics (P&T) Committee will consider the relative clinical effectiveness and relative cost effectiveness of pharmaceutical agents in a therapeutic class in recommending the selection of agents for the DoD Uniform Formulary (UF) and, for cost sharing purposes, the classification of a pharmaceutical agent as generic, formulary, Basic Core Formulary (BCF), Extended Core Formulary (ECF), or non-formulary (NF). Prior to the scheduled P&T Committee meet

Why This Opportunity Matters

The Department of DEFENSE is actively seeking qualified contractors for pharmaceutical preparation manufacturing with a set-aside for No Set Aside businesses in JBSA FT SAM HOUSTON, TX. This set-aside designation means eligible businesses face reduced competition from larger firms.